CONTACT: BECKY SOGLIN
Iowa City IA 52242
(319) 335-6660; fax (319) 384-4638
Release: Feb. 5, 2002
UI invites women to participate in genital herpes study
University of Iowa Health Care researchers invite women with genital herpes
to participate in a study on the effectiveness of an experimental gel to prevent
or delay recurrences of the condition.
Genital herpes, the most common sexually transmitted disease, affects nearly
45 million Americans, and the outbreaks associated with the condition can
be painful and difficult to control.
Healthy women ages 18 to 65 who have frequent genital herpes outbreaks are
invited to participate in the study.
Participants must agree to use a medically acceptable form of birth control
while enrolled in the study. Participants also must be willing to make frequent
visits -- a minimum of 12 -- to UI Hospitals and Clinics.
Visits will be every other day during the first treated outbreak. Subsequent
outbreaks would require participants to report to the clinic twice during
each outbreak. In addition, scheduled visits - not related to outbreaks
- are every three months during the study. The study length is one year
after the initial treated outbreak.
Participants randomly will be provided with the gel or with placebo (inactive
substance) for application twice a week (for one week) for each recurrence.
Compensation will also be provided.
The UI study is being led by Kevin Ault, M.D., UI assistant professor of
gynecology and obstetrics. The UI is one of 125 sites nationwide, as well
as 40 in Europe, investigating the drug.
For more information, women can contact Tracy Peters at (319) 356-2719 between
8 a.m. and 4:30 p.m. Monday through Friday or by e-mail at email@example.com.
University of Iowa Health Care describes the partnership between the
UI College of Medicine and the UI Hospitals and Clinics and the patient care,
medical education and research programs and services they provide.